Condition: Atrial Fibrillation, Persistent · Heart Failure · Sponsor: University Hospital, Geneva
The goal of this clinical trial is to evaluate two treatment strategies in patients with chronic atrial fibrillation and heart failure, who are eligible for atrial fibrillation ablation. Patients will be randomized to either atrial fibrillation ablation or to implantation of a pacemaker with conduction system pacing followed by atrioventricular node ablation. The effect of treatment allocation on total mortality, cardiovascular hospitalization and heart failure hospitalization will be compared.
This description comes directly from the study's public registry record.
Haran Burri · +41794616217 · haran.burri@hcuge.ch
Nikola Kozhuharov · +41764439086 · nikola.kozhuharov@googlemail.com
Always discuss trial participation with your own doctor first.
| St Elisabeth sister's Hospital | Graz, Austria | Not Yet Recruiting |
| Antwerp University Hospital | Antwerp, Belgium | Not Yet Recruiting |
| Acibadem City Clinic Tokuda University Hospital | Sofia, Bulgaria | Not Yet Recruiting |
| University Hospital, Kralovske Vinohrady | Prague, Czechia | Not Yet Recruiting |
| Heart and Lung Center, University of Helsinki | Helsinki, Finland | Recruiting |
| Hôpital Charles Nicolle | Rouen, France | Not Yet Recruiting |
| Herzzentrum Leipzig | Leipzig, Germany | Not Yet Recruiting |
| Semmelweis University | Budapest, Hungary | Not Yet Recruiting |
| Bologna University Hospital | Bologna, Italy | Not Yet Recruiting |
| University Hospital Maastricht | Maastricht, Netherlands | Not Yet Recruiting |
| Jagiellonian University | Krakow, Poland | Not Yet Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Not Yet Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06207383